Quris Ai

Tel Aviv-yafo, Israel Founded: 2020 • Age: 6 yrs
AI-based drug candidate predicting tool for healthcare professionals

About Quris Ai

Quris Ai is a Healthcare company based in Tel Aviv-yafo (Israel) founded in 2020 by Yossi Haran and Isaac Bentwich. AI-based drug candidate predicting tool for healthcare professionals. Quris Ai has raised $37 million across 3 funding rounds from investors including iAngels, SoftBank Vision Fund and GlenRock Israel. Quris Ai has completed 1 acquisition, including Nortis. Its chief executive, as recorded, is Isaac Bentwich. Quris Ai offers products and services including Bio-AI Clinical Prediction Platform. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials. Its legal entity is Quris Technologies LTD.

Company details

Quris AI was founded in 2020 within the healthcare and biotechnology sector. Software is developed to support drug development processes through AI-driven predictions. Key features encompass clinical predictive analytics, clinical trial oversight, and overall drug development management. Operations center on enhancing efficiency for pharmaceutical workflows, with tools tailored for professional use in drug discovery and validation.

  • Headquarters Tel Aviv-yafo, Israel
  • Founders Yossi Haran, Isaac Bentwich
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website quris.ai
  • Social LinkedIn
  • Legal Name Quris Technologies Ltd
Key Metrics
  • Total Equity Funding
    $37M (USD)

    in 3 rounds

  • Latest Funding Round
    $9M (USD), Seed

    Dec 2022

  • Investors
    iAngels

    & 6 more

  • Investments & Acquisitions

Products & Services of Quris Ai

Quris Ai offers a comprehensive portfolio of products and services, including Bio-AI Clinical Prediction Platform.

Bio-AI Clinical Prediction Platform
AI Software

Predicts drug safety using machine-learning trained on bio-data.

Funding Insights of Quris Ai

Quris Ai has successfully raised a total of $37M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $9 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $37M
  • Total Rounds 3
  • Last Round Seed β€” $9M
  • First Round $9M

    (Oct 2021)

  • Investors Count 7

All 3 funding rounds of Quris Ai with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2022$9MSeed–SoftBank Vision Fund
Jan 2022$19MSeed–Welltech Ventures
Oct 2021$9MSeed–Judith Richter, Kobi Richter
Valuation history

7 investors in total: 4 institutional and 3 angel.

Investors in Quris Ai

Quris Ai has secured backing from 7 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include iAngels, SoftBank Vision Fund and GlenRock Israel.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Venture capital investments in technology and startups.
2016visionfund.comLondon, United Kingdom
Private equity investments are targeted in Israel and the US.
grg.co.ilHerzliya, Israel
WellTech Ventures is focused on investing in wellness technology startups.
welltechventures.comTel Aviv, Israel
Investors are connected to tech startups through a fundraising platform.
2014iangels.comTel Aviv, Israel

Judith Richter

unknown_9a5031ec9db844c09

Kobi Richter

Co-founder of Medinol, active angel investor in Indian startups
unknown_b930e601dd124e678

Moshe Yanai

Israeli tech innovator, angel investor, known for storage tech at EMC.
unknown_050fe2268187443f8
Premium access

Investor details for Quris Ai

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Quris Ai

36 people are tracked at Quris Ai (9 in leadership, 12 in board & advisors, 15 in team).

NameRoleGroup
Yossi Haran
Co-Founder & CTOLeadership
Isaac Bentwich
Co-Founder & CEOLeadership
Shahar Harel
Head Of AILeadership
Tal Shlisel
Head Of Office OperationsLeadership
Shelly Maman
Head Of Strategic AlliancesLeadership
Yossi Maimon
Chief Financial OfficerLeadership
Inbar Ketter
VP FinanceLeadership
Yarin Lowenhardt
VP Of EngineeringLeadership
Inbal Peled
VP Of Regulatory AffairsLeadership
Nissim Benvenisty
Board MemberBoard & advisors
Robert Langer
Board MemberBoard & advisors
Luba Greenwood
Board MemberBoard & advisors
Matthew Bronfman
Board MemberBoard & advisors
Rami Ungar
Board MemberBoard & advisors
Kobi Richter
Board MemberBoard & advisors
Moshe Yanai
Board MemberBoard & advisors
Fernando Patolsky
Board MemberBoard & advisors
Aaron Ciechanover
ChairmanBoard & advisors
Alex Bronstein
Board MemberBoard & advisors
Henry McKinnell
AdvisorBoard & advisors

16 more people are available in the full profile.

Premium access

Complete people profiles for Quris Ai

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Quris Ai

Quris Ai has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Nortis.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Small human tissue segments are generated in microfluidic chips.
nortisbio.comWoodinville, United States2007Oct 2024β€’β€’β€’β€’
Premium access

Complete acquisition details for Quris Ai

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Quris Ai

4 dated milestones of Quris Ai across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Quris Ai is founded.
  2. Funding First funding round of $9.0M.
  3. Funding Latest funding round, Seed, of $9.0M.
  4. Acquisition Acquires Nortis.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Quris Ai

Premium access

Complete news archive for Quris Ai

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Quris Ai

Quris Ai was founded in 2020 and raised its 1st funding round 1 year after it was founded.

Quris Ai is headquartered in Tel Aviv-yafo, Israel. It is registered at Tel Aviv-yafo, Tel Aviv District, Israel.

Isaac Bentwich is the CEO of Quris Ai, as recorded in our data. They have also founded this company.

Quris Ai is a funded company, having raised a total of $37M across 3 funding rounds to date. The company's 1st funding round was a Seed of $9M, raised on Oct 2021.

Quris AI was founded in 2020 within the healthcare and biotechnology sector. Software is developed to support drug development processes through AI-driven predictions. Key features encompass clinical predictive analytics, clinical trial oversight, and overall drug development management. Operations center on enhancing efficiency for pharmaceutical workflows, with tools tailored for professional use in drug discovery and validation.

Quris Ai offers Bio-AI Clinical Prediction Platform.

Quris Ai has made 1 acquisition, including Nortis.

Quris Ai has 7 investors. Key investors include iAngels, SoftBank Vision Fund, GlenRock Israel, WellTech Ventures, and Judith Richter.

Quris Ai operates through Quris Technologies Ltd.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available